| The 2020 pandemic: current SARS-CoV-2 vaccine development SO Alturki, SO Alturki, J Connors, G Cusimano, MA Kutzler, AM Izmirly, ... Frontiers in immunology 11, 562194, 2020 | 96 | 2020 |
| Challenges in dengue vaccines development: pre-existing infections and cross-reactivity AM Izmirly, SO Alturki, SO Alturki, J Connors, EK Haddad Frontiers in Immunology 11, 542949, 2020 | 53 | 2020 |
| The impact of immuno-aging on SARS-CoV-2 vaccine development J Connors, MR Bell, J Marcy, M Kutzler, EK Haddad Geroscience 43, 31-51, 2021 | 35 | 2021 |
| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... EBioMedicine 83, 2022 | 33 | 2022 |
| Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals J Connors, D Joyner, NJ Mege, GM Cusimano, MR Bell, J Marcy, ... Communications Biology 6 (1), 188, 2023 | 25 | 2023 |
| Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection H Mohamed, R Clemen, E Freund, JW Lackmann, K Wende, J Connors, ... PloS one 16 (3), e0247125, 2021 | 14 | 2021 |
| Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients J Diray-Arce, S Fourati, ND Jayavelu, R Patel, C Maguire, AC Chang, ... Cell Reports Medicine 4 (6), 2023 | 12 | 2023 |
| Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses R Muir, T Metcalf, S Fourati, Y Bartsch, J Kyosiimire-Lugemwa, ... PLoS neglected tropical diseases 17 (7), e0011089, 2023 | 8 | 2023 |
| Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonists J Connors, B Taramangalam, G Cusimano, MR Bell, SM Matt, K Runner, ... GeroScience 44 (5), 2555-2572, 2022 | 7 | 2022 |
| The 2020 pandemic: current SARS-CoV-2 vaccine development. Front Immunol 11: 1880 SO Alturki, SO Alturki, J Connors, G Cusimano, MA Kutzler, AM Izmirly, ... | 7 | 2020 |
| The 2020 pandemic: current SARS-CoV-2 vaccine development. Front Immunol. 2020; 11: 1880 SO Alturki, SO Alturki, J Connors, G Cusimano, MA Kutzler, AM Izmirly Epub 2020/09/26. https://doi. org/10.3389/fimmu. 2020.01880 PMID: 32973779, 2020 | 5 | 2020 |
| Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge EN Gary, NJ Tursi, BM Warner, G Cuismano, J Connors, EM Parzych, ... Frontiers in Immunology 14, 1138609, 2023 | 4 | 2023 |
| Improved durability to SARS-CoV-2 vaccine immunity following coimmunization with molecular adjuvant adenosine deaminase-1 GM Cusimano, EN Gary, MR Bell, BM Warner, J Connors, NJ Tursi, AR Ali, ... The Journal of Immunology 209 (1), 118-127, 2022 | 4 | 2022 |
| Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy H Mohamed, R Berman, J Connors, EK Haddad, V Miller, ... Biomedicines 11 (1), 122, 2023 | 3 | 2023 |
| Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine AM Izmirly, AN Pelletier, J Connors, B Taramangalam, SO Alturki, ... PLoS Pathogens 18 (1), e1009903, 2022 | 2 | 2022 |
| Therapeutic ROS and Immunity in Cancer—The TRIC-21 Meeting S Bekeschus, S Emmert, R Clemen, L Boeckmann Cancers 13 (18), 4549, 2021 | 2 | 2021 |
| IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition BS Haslund-Gourley, K Woloszczuk, J Hou, J Connors, G Cusimano, ... Nature communications 15 (1), 404, 2024 | 1 | 2024 |
| Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity J Connors, G Cusimano, N Mege, K Woloszczuk, E Konopka, M Bell, ... Human vaccines & immunotherapeutics 19 (3), 2267295, 2023 | 1 | 2023 |
| Aging alters immune responses to vaccines J Connors, EK Haddad, C Petrovas Aging (Albany NY) 13 (2), 1568, 2021 | 1 | 2021 |
| Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge G Cusimano, EN Gary, NJ Tursi, BM Warner, J Connors, EM Parzych, ... The Journal of Immunology 210 (1_Supplement), 252.04-252.04, 2023 | | 2023 |
Michele A. Wetzel KutzlerDrexel University College of MedicineVerified email at drexelmed.edu
